Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on September 8, 2025
Osisko Development Intercepts 57.29 g/t Gold Over 3.05 Meters, 625.95 g/t Gold Over 0.5 Meters and 15.26 g/t Gold Over 4.4 Meters in Lowhee Infill Drilling at Cariboo Gold Project
GlobeNewswire
·
September 8, 2025
MONTREAL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce results from its infill and exploration diamond drill, and development sampling campaigns in the …
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
GlobeNewswire
·
September 8, 2025
New York, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- LEA, a company providing client data automation for wealth management, today announced $1.25 million in funding led by Social Leverage, with prior participation from experienced RIA and institutional wealth …
Diginex Announces Completion of Eight to One Stock Split Paid as Bonus Shares
GlobeNewswire
·
September 8, 2025
LONDON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, today announced that it has completed the distribution of the bonus shares issuance, whereby 7 bonus ordinary …
Kleen HY-DRO-GEN INC. Announces Commencement of Trading
GlobeNewswire
·
September 8, 2025
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kleen HY-DRO-GEN Inc. (formerly 0755461 B.C. Ltd.) (the "Resulting Issuer") is pleased to announce that following …
NOVAGOLD’s 2025 Donlin Gold Drill Program Returns High-Grade Gold Intercepts, Strengthens Resource Conversion, and Supports Bankable Feasibility Study Progression
GlobeNewswire
·
September 8, 2025
Exceptional Drill Results: Drill results confirm consistent mineralization across multiple zones, including standout intervals up to 23.49 g/t gold, reinforcing Donlin Gold’s position as one of the most significant gold development projects globally. …
Computer Resources of America Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
GlobeNewswire
·
September 8, 2025
New York, NY , Sept. 08, 2025 (GLOBE NEWSWIRE) -- Computer Resources of America (CRA), a leading provider of innovative IT solutions and managed services, is proud to announce its inclusion in the prestigious 2025 Inc. 5000 list, recognizing the fastest- …
DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors
GlobeNewswire
·
September 8, 2025
NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research …
TAP Technology нацелена на население Индии в 1,4 миллиарда человек в рамках инициативы по энергетической независимости
EIN Presswire
·
September 8, 2025
Энергосистема без топлива соответствует целям программы Digital India и задачам электрификации сельских районов DUBAI, DUBAI, UNITED ARAB EMIRATES, September 8, 2025 /EINPresswire.com/ -- Компания NEO7even Holdings объявляет о стратегическом …
NYUAD researchers develop 3D-printed capsule to sample gut microbiome
EIN Presswire
·
September 8, 2025
CORAL capsule offers non-invasive access to understudied intestinal microbes ABU DHABI, ABU DHABI, UNITED ARAB EMIRATES, September 8, 2025 /EINPresswire.com/ -- Gut microbiome studies have long relied on fecal samples, which primarily represent microbes …
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
GlobeNewswire
·
September 8, 2025
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
GlobeNewswire
·
September 8, 2025
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug …
House of Doge Treasury Partner CleanCore Solutions Acquires 285,420,000 DOGE with Strategic Goal to Accumulate First Milestone Target of 1 Billion DOGE in 30 Days as the Newly Launched Official Dogecoin Treasury
GlobeNewswire
·
September 8, 2025
MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, together with their partner CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or “ZONE”), announced the successful acquisition of 285 …
PharmAla Completes Import of LaNeo MDMA for US Distribution
GlobeNewswire
·
September 8, 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
GlobeNewswire
·
September 8, 2025
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that …
CompoSecure to Move Stock Exchange Listing to NYSE
GlobeNewswire
·
September 8, 2025
SOMERSET, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO) (“CompoSecure” or the “Company”) today announced that it will transfer the listing of its Class A common stock (Nasdaq: CMPO) to the New York Stock Exchange (“NYSE”) from …
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
GlobeNewswire
·
September 8, 2025
At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are further supported by early data from open- …
Giga Metals to Launch September Geophysics Program at Turnagain Ni-Co project
GlobeNewswire
·
September 8, 2025
VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Scott Lendrum, CEO of Giga Metals Corp. (TSX.V: GIGA, OTCQB: GIGGF) announced today that following the closing of the non-brokered private placement on August 28, 2025, Giga Metals Corp. will …
Rapport Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 8, 2025
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
GlobeNewswire
·
September 8, 2025
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Abivax Presents First Half 2025 Financial Results
GlobeNewswire
·
September 8, 2025
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …